Skip to the content Skip to the Navigation
GEXVal
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)

News

  1. Top page
  2. News
Information
CTO Nakayama to Participate in the 15th International Workshop on Advanced Genomics, July 2–4, 2025, at Hitotsubashi Hall
2025/6/25

Read more
Information
CTO Nakayama to Participate in the 7th Annual Meeting of the Japanese Association for Medical Artificial Intelligence, June 27–28, 2025, at Kyoto International Conference Center
2025/6/24

Read more
Information
GEXVal to Participate in BIO International Convention 2025
2025/6/5

Read more
Information
GEXVal to Present at Bio€quity Europe 2025
2025/5/12

Read more
Information
Data-Driven Drug Discovery Platform "RePhaIND®" to be Presented at the Pharmaceutical Society of Japan Annual Meeting
2025/3/14

GEXVal Inc.March 14, 2025   Data-Driven Drug Discovery Platform "RePhaIND®︎" to be Presented at the Pharmaceut […]

Read more

Posts pagination

  • Page 1
  • Page 2
  • …
  • Page 19
  • »

Category

  • Information
  • IR
  • R&D

Copyright © GEXVal All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)